Tampa biotech’s investment struggles play a key role in creation of a new fund


    A Tampa biotech entrepreneur is going to New York — temporarily — to find mentors and investors who understand her business.

    Keriaan Greenhalgh, chairman and CEO of skin and wound care products company KeriCure, will be one of 15 founders taking part in Quake Capital’s spring 2019 cohort, a 12-week program that starts next week.

    “I’m really excited because it opens up a whole new group of people that we haven’t really had access to in Florida. Here, we’ve maxed out our resources and ability to grow, so I think it’s the right time for us to venture into a new pond,” Greenhalgh said.